{
  "hash": "83bbfa63a075da4b5221db21df39f85d",
  "result": {
    "markdown": "---\ntitle: \"Continuous Outcome\"\n---\n\n\n\n::: {.cell}\n\n```{.r .cell-code}\nlibrary(pwr)\n```\n:::\n\n\n![R Packages and functions for sample size calculation [@sample_size_calc_clinical_R]](/pic/sample-size-pkg.png)\n\n## Comparing 2 groups\n\n### Overview\n\n`pwr.t.test()` function\n\n- One-sample t test (`type` = “one.sample”)\n- Two-sample t test (`type` = “two.sample”)\n- Paired t test (`type` = “paired”)\n\n**Cohen’s d** is used as the effect size\n\n- Very small (d = 0.01)\n- Small (d = 0.2)\n- Medium (d = 0.5)\n- Large (d = 0.8)\n- Very large (d = 1.2)\n- Huge (d = 2)\n\nIn the example below, I will be used these setting for default values:\n\n- Medium effect size\n- A two-tailed test\n- A significance of **0.05** and a power of **80%**\n\n\n### One-sample t-test \n\nCohen's d:\n\n$$\nd = \\frac{\\mu_1 - \\mu_0}{SD}\n$$\n\nWhere:\n\n- $\\mu_0$ = mean under $H_0$\n- $\\mu_1$ = mean under $H_1$\n- $SD$ = SD under $H_0$\n\n#### Ex 1: New dietary supplement\n\nDoes the introduction of a new dietary supplement reduce systolic blood pressure in patients with stage 1 hypertension more effectively than the currently recommended lifestyle modifications alone?\n\nThe primary outcome is the mean change in systolic blood pressure (mmHg) after a 12-week supplementation period.\n\nLet's assume a **medium** effect size ($d = 0.5$)\n\n\n::: {.cell}\n\n```{.r .cell-code}\ncohen.ES(test = \"t\", size = \"medium\")\n```\n\n::: {.cell-output .cell-output-stdout}\n```\n\n     Conventional effect size from Cohen (1982) \n\n           test = t\n           size = medium\n    effect.size = 0.5\n```\n:::\n:::\n\n::: {.cell}\n\n```{.r .cell-code}\npwr.t.test(d = 0.5, \n           sig.level = 0.05, power = 0.8, \n           type = \"one.sample\", alternative = \"two.sided\")\n```\n\n::: {.cell-output .cell-output-stdout}\n```\n\n     One-sample t test power calculation \n\n              n = 33.36713\n              d = 0.5\n      sig.level = 0.05\n          power = 0.8\n    alternative = two.sided\n```\n:::\n:::\n\n\n**N = 34** (If dropout rate of 20%, a total of 43 samples are required) \n\n\n#### Ex 2: New DM Drug\n\nLet’s propose a study of a new drug to reduce hemoglobin A1c in type 2 diabetes over a 1 year study period. You estimate that your recruited participants will have a mean baseline A1c of 9.0, which will be unchanged by your placebo, but reduced (on average) to 7.0 by the study drug.\n\nlet’s say 5.0 and 17.0 for min and max of Hgb A1c\n\n\n::: {.cell}\n\n```{.r .cell-code}\nsd_approx <- (17 - 5)/4\nd1 <- (9 - 7) / sd_approx # delta / sd\n\npwr.t.test(\n  n = NULL,\n  sig.level = 0.05,\n  type = \"two.sample\",\n  alternative = \"two.sided\",\n  power = 0.80,\n  d = d1\n)\n```\n\n::: {.cell-output .cell-output-stdout}\n```\n\n     Two-sample t test power calculation \n\n              n = 36.30569\n              d = 0.6666667\n      sig.level = 0.05\n          power = 0.8\n    alternative = two.sided\n\nNOTE: n is number in *each* group\n```\n:::\n:::\n\n\n**N = 37** in each group (Assuming a 20% dropout rate in each arm, would require 37*5/4 subjects per arm)\n\n\nIf study on 50 participants, what would the power be?\n\n\n::: {.cell}\n\n```{.r .cell-code}\npwr.t.test(\n  n = 25, # note that n is per arm\n  sig.level = 0.05,\n  type = \"two.sample\",\n  alternative = \"two.sided\",\n  power = NULL, # ?\n  d = 0.66\n)\n```\n\n::: {.cell-output .cell-output-stdout}\n```\n\n     Two-sample t test power calculation \n\n              n = 25\n              d = 0.66\n      sig.level = 0.05\n          power = 0.6280322\n    alternative = two.sided\n\nNOTE: n is number in *each* group\n```\n:::\n:::\n",
    "supporting": [],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {},
    "engineDependencies": {},
    "preserve": {},
    "postProcess": true
  }
}